105 related articles for article (PubMed ID: 11404724)
21. Comparative assessment of blood and urine analyses in patients with acute poisonings by medical, narcotic substances and alcohol in clinical toxicology.
Ostapenko YN; Lisovik ZA; Belova MV; Luzhnikov EA; Livanov AS
Przegl Lek; 2005; 62(6):591-4. PubMed ID: 16225131
[TBL] [Abstract][Full Text] [Related]
22. Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay, and gas chromatography-mass spectrometry.
Maurer HH; Fritz CF
Int J Legal Med; 1990 Dec; 104(1):43-6. PubMed ID: 11453092
[TBL] [Abstract][Full Text] [Related]
23. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
Eichhorst J; Etter M; Lepage J; Lehotay DC
Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.
Salm P; Warnholtz C; Boyd J; Arabshahi L; Marbach P; Taylor PJ
Clin Biochem; 2006 Jul; 39(7):732-8. PubMed ID: 16725133
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of various immunologic methods with a GC-MS analysis in cannabinoid detection in urine].
Käferstein H; Sticht G; Staak M
Beitr Gerichtl Med; 1989; 47():115-22. PubMed ID: 2684146
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
Forensic Sci Int; 2005 Nov; 154(2-3):240-6. PubMed ID: 16182972
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods.
Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR
J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the CEDIA DAU assays and the AxSym system for the analysis of cannabinoids in whole blood.
Cagle JC; McCurdy HH; Pan YM; Ayton KJ; Wall WH; Solomons ET
J Anal Toxicol; 1997; 21(3):213-7. PubMed ID: 9171205
[TBL] [Abstract][Full Text] [Related]
29. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
Caplan YH; Levine B
J Anal Toxicol; 1989; 13(5):289-92. PubMed ID: 2693834
[TBL] [Abstract][Full Text] [Related]
30. Methods for the determination of phenolic brominated flame retardants, and by-products, formulation intermediates and decomposition products of brominated flame retardants in water.
López P; Brandsma SA; Leonards PE; De Boer J
J Chromatogr A; 2009 Jan; 1216(3):334-45. PubMed ID: 18762297
[TBL] [Abstract][Full Text] [Related]
31. Determination of opiates in serum, saliva and hair addicted persons.
Piekoszewski W; Janowska E; Stanaszek R; Pach J; Winnik L; Karakiewicz B; Kozielec T
Przegl Lek; 2001; 58(4):287-9. PubMed ID: 11450354
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoids in hair: strategy to prove marijuana/hashish consumption.
Uhl M; Sachs H
Forensic Sci Int; 2004 Oct; 145(2-3):143-7. PubMed ID: 15451086
[TBL] [Abstract][Full Text] [Related]
33. Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".
Cawley AT; Hine ER; Trout GJ; George AV; Kazlauskas R
Forensic Sci Int; 2004 Jul; 143(2-3):103-14. PubMed ID: 15240029
[TBL] [Abstract][Full Text] [Related]
34. Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx and dry chemistry enzyme immunoassay on the Vitros 950.
Solnica B
Clin Chem Lab Med; 2004; 42(8):958-64. PubMed ID: 15387450
[TBL] [Abstract][Full Text] [Related]
35. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
Lu NT; Taylor BG
Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
[TBL] [Abstract][Full Text] [Related]
36. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests.
Moore L; Wicks J; Spiehler V; Holgate R
J Anal Toxicol; 2001 Oct; 25(7):520-4. PubMed ID: 11599594
[TBL] [Abstract][Full Text] [Related]
37. Clinical validation of a new blood collection tube for the accuracy of total homocysteine measurement by different methods.
Bissé E; Epting T; Kögel G; Obeid R; Gempel K; Huzly D; Fuhrmann K; Rolinski B; Herrmann W; Wieland H
Clin Biochem; 2007 Jun; 40(9-10):739-43. PubMed ID: 17467680
[TBL] [Abstract][Full Text] [Related]
38. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous determination of amphetamines and amphetamine-derived designer drugs in human urine by GC-MS.
Maresová V; Chadt J; Prikryl L
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():121-4. PubMed ID: 17159795
[TBL] [Abstract][Full Text] [Related]
40. [Identification of narcotics in urine by capillary gas chromatography].
Akalaev AN; Shpagin MG; Shabolenko VP; Kovalenko AE
Sud Med Ekspert; 2004; 47(3):34-7. PubMed ID: 15230191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
